| Browse |
| Search |
| Future Titles |
 February 2010 Volume 3, Number 1 |
Cover Illustration: The cover is an artistic depiction of results described in the paper by Blankenberg et.al. wherein VEGFR imaging has been shown to detect the effects of pazopanib, a tyrosine kinase inhibitor. |
TABLE OF CONTENTS
Brief Article |
Two-dimensional Fast surface imaging using a hand-held optical device: In-vitro and in-vivo fluorescence studies |
Sarah J Erickson, Jiajia Ge, Andrea Sanchez and Anuradha Godavarty |
| Abstract Full Article |
Original Report |
Identification of genes associated with local aggressiveness and metastatic behavior in soft tissue tumors |
Isabela W Cunha, Kátia C Carvalho, Waleska W Martins, Sarah M Marques, Nair Muto, Roberto Falzoni, Rafael M Rocha, Samuel Aguiar Jr, Ana CQ Simoes, Lucas Fahham, Eduardo J Neves, Fernando A Soares and Luiz FL Reis |
| Abstract Full Article |
Evidence for DNA damage checkpoint activation in Barrett’s esophagus |
Urs von Holzen, Tina Chen, Amelie Boquoi, Joel Richter, Gary W Falk, Andres J Klein-Szanto, Harry Cooper, Sam Litwin, David Weinberg and Greg H Enders |
| Abstract Full Article |
Inhibition of thromboxane synthase activity improves glioblastoma response to alkylation chemotherapy |
Nils Ole Schmidt, Mateo Ziu, Theresa Cargioli, Manfred Westphal, Alf Giese, Peter Black and Rona Carroll |
| Abstract Full Article |
Differential effects of the proteasome inhibitor NPI-0052 against glioma cells |
Erina Vlashi, Malcolm Mattes, Chann Lagadec, Lorenza Della Donna, Tiffany Phillips, Polin Nikolay, William McBride and Frank Pajonk |
| Abstract Full Article |
Noninvasive assessment of tumor VEGF receptors in response to treatment with Pazopanib: A molecular imaging study |
Francis G Blankenberg, Zoia Levashova, Susanta K Sarkar, John Pizzonia, Marina V Backer and Joseph M Backer |
| Abstract Full Article |
Review |
Targeting p53 for novel anticancer therapy |
Zhen Wang and Yi Sun |
| Abstract Full Article |
Three paths to better tyrosine kinase inhibition behind the blood-brain barrier in treating chronic myelogenous leukemia and glioblastoma with imatinib. |
Daniele Focosi and Richard E. Kast |
| Abstract Full Article |
| Home |
| Register |
| Submit Manuscript |
| Submit Review |
| Manuscript Status |
| FAQs |
| Contributor Instructions |
| Scope |
| Editorial Board |
| Subscribe |
| Contact Us |